[Updated on Oct. 4] Integration of CiNii Articles into CiNii Research from April 1, 2022

CYP2B6 and CYP2C19 as the major enzymes responsible for the metabolism of selegiline, a drug used in the treatment of Parkinson's disease, as revealed from experiments with recombinant enzymes

Journal

Related Articles

See more

Related Data

See more

Related Books

See more

Related Dissertations

See more

Related Projects

See more

Related Products

See more

Details

  • CRID
    1370848663324980864
  • Data Source
    • Crossref
Back to top